Showing results (421-430 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|June 27, 2025
PNOC009: Convection-enhanced delivery of liposomal irinotecan in patients with newly diagnosed diffuse intrinsic pontine gliomaSabine Mueller, Cassie Kline, Alex Y Lu, et al.
Neuro-Oncology Advances|June 27, 2025
Outcomes of pediatric medulloblastoma in low- and middle-income countries: A retrospective analysis of 335 cases from 8 countriesRosdali Y Diaz-Coronado, Ana Patricia A Alcasabas, Ronnie E Baticulon, et al.
Neuro-Oncology Advances|June 27, 2025
Arterial spin labeling perfusion MRI differentiates between radiation necrosis and tumor in brain metastases treated with stereotactic radiosurgeryHenry H Nguyen, Nathan N Ng, Shriya Awasthi, et al.
Neuro-Oncology Advances|July 4, 2025
The effect of antidepressants on glioblastoma survival: A systematic review and meta-analysisYifei Sun, Mohammad Hamo, Travis Atchley, et al.
Neuro-Oncology Advances|June 30, 2025
Health-related quality of life and psychological distress in patients with brain tumors and their families: A cross-sectional web surveyIori Sato, Mari Ikeda, Akemi Tsumura, et al.
Neuro-Oncology Advances|June 30, 2025
Correction to: Directionally non-rotating electric field therapy delivered through implanted electrodes as a glioblastoma treatment platform: A proof-of-principle study
Neuro-Oncology Advances|December 31, 2025
Intracerebral hemorrhage risk in glioma patients taking direct oral anticoagulants as compared with low molecular weight heparinRadhika S Amin, Scott Cameron, Matthew M Grabowski, et al.
Neuro-Oncology Advances|December 31, 2025
Assessment of 18F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteriaGarry Ceccon, Michael Wollring, Isabelle Stetter, et al.
Neuro-Oncology Advances|December 31, 2025
H3K27M- and BRAF V600E-Altered gliomas and glioneuronal tumors-clinico-pathologic and radiologic perspective in a cohort treated with targeted therapyCarolyn G Chen, Vanessa Rameh, Tom Rosenberg, et al.
Neuro-Oncology Advances|December 31, 2025
Relation between tumor treating fields usage rate ≥75% for the first 3 months and progression-free survival in patients with newly diagnosed WHO grade 4 gliomasShoichi Deguchi, Masashi Kinoshita, Fumiharu Ohka, et al.
Pageof 134